As digital companies move into the health space, who does the British public trust to provide medicines and health services? Research by the IPA Healthcare Groupsuggests that new entrants into the health space are disrupting – and surprisingly boosting trust in traditional pharmaceutical companies.
The IPA research collected data from 2,000 adults using the Bilendi UK Panel. The nationally representative survey asked how much the public would trust the following sectors to offer advice on diet, physical health and mental health. It asked about trust to provide medications for minor, self-limiting conditions, such as skin or allergies, prescription medicines, right up to whether these sectors or companies would be trusted to provide a non-invasive procedure or minor operation.
Sarah Sowerby, Chair of The IPA Healthcare Group and Founder of Wordbird says:
“This IPA Insights research shows that pharmaceutical companies are still front runners for trusted medical treatments. This is encouraging and challenges 2018 research suggesting trust in the pharmaceutical industry was at a five year low. There is no doubt that health is an attractive space for nimble, tech-savvy companies and younger consumers are very open to this.”